Literature DB >> 19769474

Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others?

Agnete Egilsdatter Kristoffersen1, Vinjar Fønnebø, Arne J Norheim.   

Abstract

INTRODUCTION: One reason for patients with cancer to use complementary and alternative medicine (CAM) is that their cancer cannot be cured by conventional therapy. The aim of the present study is to explore whether use of CAM is associated with survival prognosis in long-term survivors of cancer.
MATERIALS AND METHODS: Cancer patients who were alive 5 years or more after diagnosis were chosen to participate in the study, one group with less than 20% and another group with 40%-60% expected five-year survival at the time of diagnosis. A total of 735 patients received a four-page postal questionnaire about CAM use; 397 questionnaires were returned (response rate = 54%).
RESULTS: The results are reported at five levels of CAM use. The poor prognosis group reported CAM use more often than the better prognosis group; however, only significantly higher at CAM level 2 (use of a CAM provider) (p = 0.021) and in use of self-support/CAM techniques (p < 0.001). Use of over-the-counter (OTC) dietary supplements and use of diet as treatment were not significantly different between the groups. DISCUSSION: This study supports the suggestion that use of a CAM therapist and use of self-support/CAM techniques might be associated with less hope of cure given by the physician.

Entities:  

Mesh:

Year:  2009        PMID: 19769474     DOI: 10.1089/acm.2008.0262

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  20 in total

1.  Development and evaluation of a complementary and alternative medicine use survey in African-Americans with acquired immune deficiency syndrome.

Authors:  Ashli Owen-Smith; Claire Sterk; Frances McCarty; Dana Hankerson-Dyson; Ralph Diclemente
Journal:  J Altern Complement Med       Date:  2010-05       Impact factor: 2.579

2.  Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.

Authors:  Yakir Segev; Ofer Lavie; Nili Stein; Walid Saliba; Noah Samuels; Eiman Shalabna; Orit Gressel Raz; Elad Schiff; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.603

3.  Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Britt Wanta
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

4.  Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  BMC Complement Altern Med       Date:  2012-01-12       Impact factor: 3.659

5.  In vitro screening of tumoricidal properties of international medicinal herbs: part II.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2010-12       Impact factor: 5.878

6.  Complementary and alternative medicine use among patients with thoracic malignancies.

Authors:  Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

7.  Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.

Authors:  Kah Hoong Chang; Rachel Brodie; Mei Ann Choong; Karl J Sweeney; Michael J Kerin
Journal:  BMC Cancer       Date:  2011-05-24       Impact factor: 4.430

8.  The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study.

Authors:  Huiyan Ma; Catherine L Carpenter; Jane Sullivan-Halley; Leslie Bernstein
Journal:  BMC Cancer       Date:  2011-06-06       Impact factor: 4.430

9.  Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.

Authors:  Joel Yarney; Andrew Donkor; Samuel Y Opoku; Lily Yarney; Isaac Agyeman-Duah; Alice C Abakah; Emmanuel Asampong
Journal:  BMC Complement Altern Med       Date:  2013-01-19       Impact factor: 3.659

10.  Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.